Transform how you analyse drug development risk
With the only transparent analysis of drug development risk at the product level.
Jonathan, a world-recognised leader in market intelligence and analysis for the pharmaceutical sector, has led the way in creating new industry standards for forecasting global drug sales and other performance metrics.
Prior to founding EvaluatePharma in 1996, Jonathan was a top-ranked pharmaceutical analyst in the London investment-banking arena, where his insights guided venture capital and securities investments.
He earned a Masters in Management from the London Business School, and Bachelor of Medicine and Bachelor of Surgery degrees from the University of Bristol in the UK.
As Chief Executive Officer, Deborah brings to Evaluate over 30 years of expertise in the global pharmaceutical, healthcare and information sectors.
Deborah joined Evaluate in 2019 from the Department for International Trade in the UK government where she served as Managing Director of Healthcare UK, Lifesciences and Bio-economy industry sectors. Prior to that, she held senior corporate and operational roles at both private and government organisations in the UK, Europe and Asia, including as President Asia Pacific of IMS Health (now IQVIA), where she led all aspects of the business across a diverse 16-country region.
Frank joined Evaluate in 2017 as Chief Revenue officer. He brings over 20 years of Board-level experience building and leading global Sales, Marketing, Client Success and Product Development organisations.
Frank has had broad and diversified success achieving significant revenue and EBITA growth for private and publicly traded companies with “high-ticket” enterprise solutions in SaaS, on premise, and professional services offerings. Prior to Evaluate, he held executive management roles at companies including UpToDate, Arch Wireless and Forrester Research. Frank’s business education background includes studies at Boston University, Babson College and Harvard University Executive Management programs.
Nick joined Evaluate in September 2017 as Chief Financial Officer. He brings over 25 years of executive level finance, change management and business process improvement expertise.
Nick served as CFO with various investor fueled growth companies as well as large multinationals including Conagra Foods, International Paper and DuPont where he has had divisional finance responsibility for EMEA. In recent years he has worked as a consultant in London driving business and organisational change in FTSE100 businesses and Government including the Cabinet Office and the Home Office.
Jemma joined Evaluate in 2014 as Chief Commercial Officer and led the creation of the Evaluate Custom Solutions business.
Prior to Evaluate, Jemma was a Principal at Bain & Company, London with over 12 years of consulting experience. She holds a MBA from INSEAD and a BA in Modern Languages from Oxford University.
Ian joined Evaluate in 2018 and holds the position of Chief Operating Officer. He brings over 20 years of experience as a senior operations executive, including as the Managing Director of Global Operations at S&P Capital IQ (now S&P Global), a financial data and analytics provider.
A founder of Capital IQ in the UK, Ian took the company through acquisition by Standard and Poor’s in 2004, ultimately growing the European business and overseeing global business operations. Other roles include Head of Data Operations at Perform Media and two years teaching in Southern Japan.
Anthony leads Evaluate's analyst teams, currently numbering over 95 staff globally, providing life science sector analysis and commercial insight into the biotechnology, pharmaceutical and medical device industries.
Anthony joined EvaluatePharma in 1997 and has been responsible for content development and strategy, to continually enhance the value of Evaluate services to its client base. He is an economics graduate of the London School of Economics and Political Science.
Lucy joined Evaluate in 2009, holding a variety of people-centric roles before assuming the role of Evaluate’s Chief Human Resources Officer in 2018.
An experienced operational and people leader with a varied industry experience, Lucy is responsible for all aspects of HR & Corporate Services globally. Prior to joining Evaluate, Lucy held roles at Goldman Sachs and Enterprise. She has a MA in International Business, as well as CIPD and PgC qualifications.